Call our 24 hours, seven days a week helpline at 800.272.3900
Let us connect you to professionals and support options near you. Please select an option below:
Use Current LocationUse Map Selector
The Alzheimer's Association expands upon comments made in their external review of the aducanumab report from the Institute for Clinical and Economic Review (ICER).
Don’t just hope for a cure, help us find one. Participating in a clinical trial, whether you’re living with the disease or not, can make a big difference.
Clinical trials provide many participants access to cutting-edge treatments and expert medical care. And someday, they will lead us to the end of Alzheimer’s.
Join us in Boston and online for the latest research and clinical trial findings about the roles of innate and adaptive immunity in Alzheimer’s and dementia.
Help advance Alzheimer's research using our free TrialMatch matching tool.
The National Institute on Aging (NIA) launches a website for creating customizable recruiting materials for communities of color, as reported at AAIC 2021.
In the News | NPR
New recommendations for clinical trial sponsors & dementia researchers provide guidance to better communicate with participants when studies end early.
In the News | CNN
In the News | AlzForum
The Alzheimer’s Association is disappointed by the topline Phase 3 data reported today by Genentech and Roche from the Phase 3 clinical trials of gantenerumab.
Neither gantenerumab or solanezumab met its primary outcome, which was a slowing of cognitive decline as measured by multiple tests of thinking and memory.
Black History Month event brings together leaders to discuss strategies for engaging Black Americans in Alzheimer’s and dementia research and clinical trials.
Bipartisan Legislation to Support Equity in Alzheimer’s Clinical Trials Endorsed by Alzheimer’s Association, Alzheimer’s Impact Movement
Leaders in health equity have issued an urgent call to address the underrepresentation of U.S. Latinos in Alzheimer's and dementia clinical trials.
Analysis Conducted by Independent Data Monitoring Committee Indicated 2 Phase 3 Trials of Aducanumab Unlikely to Be Successful
Phase III Studies of Elenbecestat in People With Early Alzheimer's Had Safety Issues, Causing Eisai and Biogen to Discontinue Clinical Trials
The results of several clinical trials exploring both drug and non-drug strategies to address Alzheimer's disease & dementia were reported at AAIC 2022.
Plus, Part the Cloud awards $4.75 million to six new, innovative clinical trials
Alzheimer's News 3/20/2012 | Alzheimer's Association
The Alzheimer’s Association commits $10.85 million to a venture capital fund that invests in companies developing promising treatments for Alzheimer’s.
Funding will help expand the Dominantly Inherited Alzheimer’s Network Trials Unit to include anti-tau drugs
Alzheimer News 6/30/2008 | Alzheimer's Association
The Alzheimer’s Association is disappointed by the topline results from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s (A4) Study of solanezumab.
The Alzheimer’s Association is pleased with the announcement today that the FDA has revised the prescribing label for Aduhelm™ (aducanumab).
The Alzheimer’s Association celebrates Maria C. Carrillo, Ph.D., chief science officer, Alzheimer’s Association, for receiving the Lifetime Achievement Award
The Alzheimer’s Association and the Alzheimer’s Impact Movement (AIM) commend the passage of the fiscal year 23 (FY23) budget
An expert work group has developed an improved definition of clinical meaningfulness in Alzheimer's.
Global research program provides strategic funding to fuel Alzheimer’s and dementia science and accelerate treatment
The Alzheimer's Association, along with other clinical research experts, announced The National Treatment and Diagnostic Alzheimer's Registry.
The Alzheimer’s Association enthusiastically welcomes the positive topline data reported today by Eisai and Biogen
Alz News 03-03-10 | Alzheimer's Association
Plus, Two Treatment Trials Tackle Sleep Problems in People With Dementia
August 17, 2010 | Alzheimer's Association
Alzheimer's News 8/24/2012 | Alzheimer's Association
The Alzheimer’s Association commends CMS for taking action to expand coverage of brain amyloid PET imaging for the diagnosis of Alzheimer’s disease.
Significant Part the Cloud Research Funding to Examine Adult Stem Cells and Neuroinflammation
Alzheimer News 7/21/2008 | Alzheimer's Association
CMS has created unnecessary barriers for individuals with Alzheimer’s disease.
Leading researchers and community leaders convene in Tempe, Ariz. on February 8-9
New report highlights the Association’s wide-ranging work in engaging diverse communities in reducing health disparities and achieving health equity.
Alzheimer’s Association Encouraged to Learn Biogen Pursuing Regulatory Approval
The Alzheimer's Association will convene the Private Partner Scientific Board (PPSB) of the extension of ADNI4.
This unparalleled commitment stands as the largest single-year investment since the organization’s founding in 1980.
Key provisions of ENACT Act, strengthened FDA accelerated approval pathway, $226 million increase for research, $33 million to fund Alzheimer’s public health.
Alzheimer’s Association offers guidance to America’s 11 million Alzheimer’s caregivers
First Phase of Nationwide Study Demonstrates Clinical Impact of Amyloid PET Imaging
Award-Winning Playwright Raises Awareness with New Production
Today’s draft decision by the Centers for Medicare & Medicaid Services (CMS) is shocking discrimination against everyone with Alzheimer’s disease.
Rare Gene Variant Could Lead to New Alzheimer’s Treatments
2022 Facts and Figures report covers the latest Alzheimer's data, and the need to increase public and physician awareness of mild cognitive impairment (MCI).
Annual report shows more than 6 million Americans are living with Alzheimer’s
The Alzheimer’s Association®, with the GHR Foundation and Edward Jones, announced a $14 million commitment
Part the Cloud, in partnership with the Alzheimer’s Association, was announced today as Best Health Fundraising Event in the 2nd Annual Anthem Awards.
Alzheimer’s Association Part the Cloud Program Takes the Field a Step Closer to Effective Therapy With Five New Grants
Alzheimer's News 09/27/11 | Alzheimer's Association
Alzheimer's News 1/30/2013 | Alzheimer's Association
Leading voices in the Alzheimer’s and dementia scientific community underscored that Aduhelm™ (aducanumab) be made available to the population who may benefit.
Tech titans, business leaders, and celebrities raise millions of dollars, and awareness, for critical Alzheimer’s research
Alzheimer News 6/12/2008 | Alzheimer's Association
Alzheimer's News 4/11/2013 | Alzheimer's Association
We welcome today’s announcement of a National Coverage Determination (NCD) analysis, consistent with the Alzheimer’s Association position.
In the News | Alzheimer's Association
Effort Seeks to Help Health Systems Improve Health Outcomes
Alzheimer's News 7/5/2013 | Alzheimer's Association
Bill Gates Funds $10 Million Grant in Match Challenge to Fuel Research and Accelerate Alzheimer’s Treatment
UPDATED: The Alzheimer’s Association celebrates the FDA action to grant traditional approval to Leqembi (lecanemab) for the treatment of early Alzheimer’s.
A valuable Alzheimer’s disease diagnostic tool, PET scans, will now be more accessible across the country thanks to today's Medicare & Medicaid policy change.
Alzheimer's News 9/14/2011 | Alzheimer's Association
Alzheimer’s Association, Rainwater Charitable Foundation Join Forces
Alzheimer’s Association and Rainwater Charitable Foundation continue efforts to accelerate drug discovery
Results from the COSMOS-Mind study of more than 2,200 older adults found that taking a daily multivitamin-mineral supplement resulted in a cognitive benefit.
Researchers Call for Caution
October 14, 2008 | Alzheimer's Association
Alzheimer News 8/11/2010 | Alzheimer's Association
Alzheimer News 4/28/2010 | Alzheimer's Association
SPRINT MIND 2.0 to Clarify Role of Intensive Blood Pressure Lowering in Reducing Dementia Risk
Production aims to reduce Alzheimer’s disease stigma, educate and entertain underserved communities
More than 200 attendees gathered to hear from leading Alzheimer’s experts about how Part the Cloud propels progress in dementia research.
Alzheimer's News 2/5/2014 | Alzheimer's Association
The Alzheimer’s Association welcomes Donna M. Wilcock, Ph.D., as the new Editor-in-Chief of Alzheimer’s and Dementia: The Journal of the Alzheimer’s Association
The Alzheimer's Association welcomes the positive data on the Phase 3 clinical trial of donanemab for treatment of early symptomatic Alzheimer's disease.
The 2023 Facts and Figures report examines patients' and doctors' reluctance to address memory concerns, which hinders diagnosis and access to new treatments.
The Alzheimer’s Association and the NFL Alumni Association (NFLA) announced a new partnership today.
Alzheimer's News 3/5/2014 | Alzheimer's Association
Legislation to Educate Clinicians on Care Planning Services Available Through Medicare
The Alzheimer’s Association and Gdavis Productions team up to shed light on the importance of early detection of Alzheimer’s and reducing health disparities.
Alzheimer's News 4/11/2012 | Alzheimer's Association
Alzheimer News 4/21/2008 | Alzheimer's Association
New statement to medical community demands a dignified diagnosis of dementia | Alzheimer's Association
Alzheimer's News, 3/24/15 | Alzheimer's Association
Grants Support New Approaches to Treatment of Alzheimer’s and Other Dementias
The Alzheimer’s Association and University College London (UCL) are partnering to study brain aging and dementia
The Alzheimer’s Association and Alzheimer’s Impact Movement (AIM) commend Congressional leaders for today’s decision to advance a series of bipartisan policies
Improving HOPE for Alzheimer’s Act, Funding for BOLD Infrastructure for Alzheimer’s Act Signed Into Law
New partnership announced to support Black Americans living with Alzheimer’s disease and other dementias and their caregivers.
Appointment of public health veteran and current Association president signals continued focus on scientific progress and access for treatments
Up to 5 finalists will be selected to pitch their innovations to win $25K in awards
Public health veteran and Association president signals continued focus on scientific progress and access for treatments for all who will benefit
The Alzheimer’s Association and MATTER selected the winner and runners up in the competition to develop new tools for early assessment of Alzheimer's.
Alzheimer’s Association advocates flood Senate budget hearings to push HHS secretary to cover Alzheimer’s treatments.
New PSAs from the Ad Council, Alzheimer’s Association and NASCAR encourage families to talk about seeing a doctor together at the first signs of dementia.
Tony Gonzales testified before the House Ways and Means Health Subcommittee on what access to treatments would mean for the Alzheimer’s community.
During Alzheimer’s & Brain Awareness Month, the Association is ramping up its efforts to make FDA-approved treatments for early-stage Alzheimer's accessible.
Together, the Alzheimer’s Association and The Links, Incorporated, will provide Alzheimer’s disease information and resources to Black American communities.
New Studies Show Some Vaccines May Lower Alzheimer’s Risk
Alzheimer's News, 10/21/2013 | Alzheimer's Association
Business leaders, tech titans, professional athletes, and philanthropists came together to raise awareness and money for Alzheimer’s research.
The Association will work with payers & health systems to deliver broad access, calling on CMS to open reconsideration of its National Coverage Determination.
Athletes Personally Impacted by Alzheimer’s
Alzheimer News 3/24/2009 | Alzheimer's Association
Museum Programs Inspire Those Facing Alzheimer’s
In the News | Future of Personal Health
In the News | Healio
In the News | MedPage Today
In the News | HealthWell Foundation
Includes First Report of 18-Month Results From Phase 2/3 Trial of Inhaled Insulin in MCI and Alzheimer’s
In the News | McKnight’s Long-Term Care News
In the News | Neurology Live
In the News | Verywell Health
FDA Advisory Committee unanimously endorsed the efficacy and clinical benefit of lecanemab as part of the traditional approval process for this treatment.
The Alzheimer’s Association appreciates the generosity of the Erb Family Foundation and its ongoing commitment to advance Alzheimer’s and dementia research
Alzheimer News 4/16/09 | Alzheimer's Association
Plus, First Clinical Intervention for LGBT People With Alzheimer’s and Caregivers
As the global nonprofit leader in Alzheimer’s research and science we have extensively reviewed the clinical trial data for AduhelmTM (aducanumab).
Leaders of the U.S. POINTER Study announced a historic milestone: recruiting for the clinical trial has been successfully completed.
The Alzheimer’s Association welcomes and is further encouraged by the full Phase 3 data presented from the global Phase 3 clinical trial of lecanemab.
The pandemic has caused significant disruption to all aspects of life — including Alzheimer’s clinical research worldwide — as well as unprecedented innovation.
C.A.R.E. Pharmacy Award winner announced | Alzheimer's Association
First guidelines published for brain amyloid imaging in Alzheimer’s | Alzheimer's Association
Association Files Formal Request for Reconsideration of National Coverage Determination
Alzheimer's Network for Treatment and Diagnostics (ALZ-NET) collects long-term clinical & safety data from patients treated with FDA-approved therapies.
The Alzheimer's Association will award up to $5 million in funding to platforms outside the U.S. through the Global Real-World Data Platforms Program (ALZ-RWD).
Despite Biogen's decision about discontinuing Aduhelm (aducanumab), the Alzheimer’s Association is optimistic about the future of Alzheimer’s treatments.
The expanded study will be the first large-scale investigation of how lifestyle interventions affect Alzheimer’s and dementia in the brain.
Alzheimer's News 04/19/2011 | Alzheimer's Association
Lisa Barnes, Ph.D. is the new deputy editor of Alzheimer's & Dementia, the Alzheimer's Association's journal.
Alzheimer's Association statement on florbetapir PET amyloid imaging | Alzheimer's Association
Association Renews Urgent Call for CMS to Cover FDA-Approved Alzheimer’s Treatments
Alzheimer's News 01/18/12 | Alzheimer's Association
The Alzheimer’s Association enthusiastically welcomes today’s historic FDA approval of aducanumab (Biogen/Eisai) for treatment of Alzheimer’s disease.
The Alzheimer's Association and members of the Early Stage Advisory Group urged the FDA to recommend traditional approval of Leqembi.
Some Researchers Fight Alzheimer’s In and Out of the Lab
Alzheimer News 9/29/2008 | Alzheimer's Association
Alzheimer News 8/10/2009 | Alzheimer's Association
The Alzheimer’s Association welcomes the approval of brexpiprazole (Rexulti®), the first FDA-approved treatment to address dementia-related agitation.
Association one of three BOLD public health centers of excellence in the country
Alzheimer’s Association and American College of Radiology (ACR) announce recruiting for the New IDEAS Study
Today, the Alzheimer’s Association and the Alzheimer’s Impact Movement (AIM) are proud to support the introduction of two bipartisan bills
The 2024 Facts & Figures report also shows the latest national & state-by-state statistics on Alzheimer’s disease prevalence, mortality, costs & more.
"Unforgettable," a family drama that tells the story of a Black and Hispanic family facing Alzheimer's, is touring the country in 2024.
Alzheimer's News 3/15/2012 | Alzheimer's Association
Alzheimer's News 4/6/2012 | Alzheimer's Association
Alzheimer’s Association, Alzheimer’s Impact Movement Request Approved by Full Senate
Document outlines evidence-based strategies to address key care concerns. More than 30 long-term and community-based care provider groups supporting effort.
$354 million Alzheimer’s and dementia research funding increase proposed
The Alzheimer’s Association and the National Hispanic Medical Association (NHMA) are partnering to increase concern and awareness of Alzheimer’s disease and all
Training and exam are aimed at implementing latest evidenced-based practices to ensure quality dementia care for a growing number of Americans
Evidence Shows These Three Healthy Diets Can Benefit the Brain
What Can We Do to Prevent Alzheimer’s? This Question Has Been Asked by Concerned Individuals, Researchers for Years
Alzheimer's News, 3/5/2015 | Alzheimer's Association
ECHO Model to Emphasize High-Quality, Person-Centered Care in Long-Term, Community-Based Care Settings
To address the growing public health crisis of dementia, three leading organizations announced funding for 23 small-scale pilot projects
The Alzheimer’s Association and the National Academy of Neuropsychology (NAN) have awarded $800,000 in grants to researchers focusing on the impact of COVID-19
Dementia researchers at all career stages will gather Dec. 6-9 in Nairobi, Kenya at Dementia and Brain Aging in Low- and Middle-Income Countries (LMICs)
The Alzheimer’s Association and AIM are proud to support the reintroduction of the NAPA Reauthorization Act and the Alzheimer’s Accountability & Investment Act.
The Alzheimer’s Association and bipartisan advocates urged the HHS secretary to cover FDA-approved Alzheimer’s treatments in this week's House budget hearings.
Researchers Are Zeroing in on Promising Theories
Communities of Faith Spread the Word About Dementia
Studies Link Formal Education to Reduced Risk of Alzheimer's
What Your Genes Can and Can’t Tell You
Exercise May Lower Risk for Cognitive Decline
Research Shows the Brain Benefits from Good Sleep
Why You Should Get a Cognitive Assessment, and What to Expect
The Alzheimer's Association enthusiastically welcomes the announcement of a new CMS initiative to improve the way dementia care is delivered.
The roundtable will convene experts across the healthcare industry to establish consistent processes and protocols for dementia care navigation.
Leading tau experts from academia, industry and government will meet in Washington, D.C., and online to discuss this essential aspect of dementia research.
Alzheimer News 9/22/2008 | Alzheimer's Association
Report Provides Latest Alzheimer’s Prevalence, Incidence, Mortality and Costs of Care Data
An important effort to help state and local health departments address brain health across the life course.
The Alzheimer’s Association recognized six pioneers in neuroscience research and mentorship at the third AAIC® Neuroscience Next conference.
Brain Donation Helps Researchers Continue the Fight Against Alzheimer’s
New PSAs from Ad Council and Alzheimer’s Association Remind Families to Discuss Cognition Concerns Early
Donate Now
Take the Brain Tour
Learn More